Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Optimizing Prosthetic Prescription to Mitigate the Effects of Perspiration

NCT: NCT07024342 · ACTIVE_NOT_RECRUITING

NCT IDNCT07024342
StatusACTIVE_NOT_RECRUITING
Start Date2022-10-04
Completion2027-02
SponsorVA Puget Sound Health Care System (FED)
First posted
Last updated

Brief Summary

The specific aim of this research is to compare three clinically available liners, each intended to address problems of residual limb perspiration, with the as-prescribed liner of lower limb prosthesis user and determine their effect on stability, suspension, and comfort.

Frequently Asked Questions

What is Optimizing Prosthetic Prescription to Mitigate the Effects of Perspiration?

Optimizing Prosthetic Prescription to Mitigate the Effects of Perspiration is a clinical trial registered under NCT07024342. Current status: ACTIVE_NOT_RECRUITING.

What is the status of NCT07024342?

The current status of NCT07024342 (Optimizing Prosthetic Prescription to Mitigate the Effects of Perspiration) is: ACTIVE_NOT_RECRUITING.

When did Optimizing Prosthetic Prescription to Mitigate the Effects of Perspiration start?

Optimizing Prosthetic Prescription to Mitigate the Effects of Perspiration started on 2022-10-04.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑